{
  "legislationId": "119_HR_8160",
  "lastUpdate": "2026-03-31T11:28:39.548Z",
  "history": [
    {
      "timestamp": "2026-03-31T11:28:39.548Z",
      "source_url": "https://www.congress.gov/119/bills/hr8160/BILLS-119hr8160ih.htm",
      "model": "gemini-flash-lite-latest",
      "prompt_sent": "\nROLE: Fact Checker.\nZADANIE: Porównaj SOURCE (oryginał) i SUMMARY (streszczenie przygotowane przez inne AI).\n\nTwoim celem jest wykrycie \"ZMYŚLONYCH KONKRETÓW\" (Fabricated Entities) w SUMMARY.\n\nSOURCE:\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8160 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8160 To expand research, improve awareness, and increase access to treatment for individuals affected by Premenstrual Dysphoric Disorder, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 30, 2026 Ms. Ansari (for herself, Mrs. Beatty, Mr. Bell, Ms. Brownley, Mr. Carter of Louisiana, Ms. Clarke of New York, Mr. Conaway, Mr. Goldman of New York, Mrs. Grijalva, Mr. Jackson of Illinois, Mr. Johnson of Georgia, Mr. Kennedy of New York, Mr. Krishnamoorthi, Mr. McGarvey, Ms. Norton, Ms. Pressley, Ms. Ross, Mr. Thanedar, Ms. Tlaib, Mr. Tonko, Mrs. Trahan, Ms. Velazquez, Ms. Williams of Georgia, and Ms. Wilson of Florida) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To expand research, improve awareness, and increase access to treatment for individuals affected by Premenstrual Dysphoric Disorder, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Premenstrual Dysphoric Disorder Awareness and Research Act of 2026''. SEC. 2. FINDINGS. Congress finds the following: (1) Premenstrual Dysphoric Disorder (referred to in this section as ``PMDD'') is a severe, chronic, and often disabling medical condition affecting an estimated 5 to 8 percent of women and people assigned female at birth of reproductive age. (2) PMDD is characterized by extreme mood shifts, irritability, depression, anger, hopelessness, tension, anxiety, and physical symptoms, such as difficulty concentrating, change in appetite, decreased energy, over or under sleeping, or joint and muscle aches, in the luteal phase of the menstrual cycle, significantly impairing work, education, and daily life. (3) Despite its prevalence and debilitating impact, PMDD remains under-diagnosed, under-researched, and stigmatized. (4) Early detection, effective treatment, and increased public and provider awareness are essential to improving quality of life for individuals living with PMDD. SEC. 3. RESEARCH WITH RESPECT TO PREMENSTRUAL DYSPHORIC DISORDER (PMDD). (a) In General.--The Secretary of Health and Human Services (in this section referred to as the ``Secretary''), acting through the Director of the National Institutes of Health, shall-- (1) expand and intensify research on Premenstrual Dysphoric Disorder (referred to in this section as ``PMDD''), including the causes, risk factors, diagnosis, and treatment of PMDD; (2) support clinical trials to develop improved treatment options for PMDD; and (3) ensure adequate representation of diverse racial, ethnic, and socioeconomic populations in PMDD-related research. (b) Surveillance and Data Collection.--The Secretary shall collect and publish data on-- (1) the prevalence and incidence of PMDD across populations; (2) the economic and workforce impact of PMDD; and (3) barriers to diagnosis and treatment of PMDD. (c) Authorization of Appropriations.--To carry out this section there are authorized to be appropriated such sums as is necessary for each of fiscal years 2027 through 2031. SEC. 4. EDUCATION AND DISSEMINATION OF INFORMATION WITH RESPECT TO PREMENSTRUAL DYSPHORIC DISORDER (PMDD). (a) In General.--The Secretary shall carry out a public health awareness campaign that is designed to-- (1) raise patient and health care provider awareness of PMDD symptoms and treatment options; (2) reduce stigma associated with menstrual health conditions; and (3) encourage individuals to seek timely medical care. (b) Provider Education.--The Secretary, acting through the Administrator of the Health Resources and Services Administration, shall develop, and disseminate, continuing medical education materials to ensure that health care providers have sufficient knowledge-- (1) to accurately diagnose PMDD; (2) to distinguish PMDD from other mental health and gynecological conditions; and (3) to provide evidence-based care. (c) Coordination.--In carrying out this section, the Secretary shall coordinate with existing awareness, education, and outreach programs and activities of the Department of Health and Human Services. (d) Authorization of Appropriations.--To carry out this section there are authorized to be appropriated such sums as is necessary for each of fiscal years 2026 through 2030. SEC. 5. GRANTS TO TRAIN HEALTH PROFESSIONALS WITH RESPECT TO PMDD. (b) In General.--The Secretary shall award grants to eligible entities for the purpose described in subsection (b). (c) Use of Funds.--A grant awarded under this subsection shall be used to develop, establish, or expand training programs (including accredited residency programs, fellowships, or other related clinical training) for physicians, registered nurses, nurse practitioners, physician assistants, pharmacists, other health care providers, and students and trainees to improve care, treatment, or management services for PMDD. (d) Eligibility.--To be eligible to receive a grant under this subsection, an entity shall-- (1) be-- (A) an accredited school of medicine or osteopathic medicine; (B) an accredited nursing school; (C) an accredited school of pharmacy; (D) an accredited public or nonprofit private hospital; (E) an accredited medical residency program; (F) an accredited nurse practitioner residency program; or (G) a related training program for clinicians, allied health professionals, or social workers that interface with affected populations, which may include hospitals and research institutions, as determined by the Secretary; and (2) submit an application to the Secretary at such time, in such manner, and containing such information as the Secretary may require. (e) Training Opportunities.--In carrying out this section, the Secretary shall expand outreach activities to support and expand training programs, fellowships, and other opportunities for students, faculty, and trainees (including continuing medical education) or establish new training opportunities to address barriers to access to-- (1) primary and specialty care services to support mid-life women's health; and (2) early detection, diagnosis, treatment, and care services for perimenopause, menopausal symptoms, and related chronic conditions. (f) Authorization of Appropriations.--To carry out this section there are authorized to be appropriated such sums as is necessary for each of fiscal years 2027 through 2031. SEC. 6. REPORT ON IMPACTS ON PMDD RESEARCH AND TREATMENT. (a) Report.--Not later than 2 years after the date of the enactment of this Act, the Secretary shall submit to Congress a report on progress made in-- (1) expanding PMDD research; (2) improving awareness of, and education on, PMDD; and (3) increasing access to diagnosis of, and treatment for, PMDD. (b) Authorization of Appropriations.--To carry out this section there are authorized to be appropriated such sums as is necessary for each of fiscal years 2027 through 2031. <all>\n\nSUMMARY TO EVALUATE:\nTitle: Premenstrual Dysphoric Disorder Awareness and Research Act of 2026\nSummary: This bill aims to improve the lives of people with PMDD by funding more research and better training for healthcare providers. It focuses on making diagnosis faster and treatments more accessible while reducing the social stigma of the condition.\nKey Points: Increased funding for research into PMDD causes, risk factors, and new treatment options., Public awareness campaigns to help patients and healthcare providers recognize symptoms and seek care., Grants for training programs to help doctors, nurses, and other health professionals manage PMDD effectively., Collection of data on how PMDD affects the workforce, the economy, and access to medical services.\n\nZASADY OCENY:\n1. Sprawdź wszystkie LICZBY, DATY i KWOTY w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n2. Sprawdź wszystkie NAZWISKA, ORGANIZACJE i MIEJSCA w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n3. Sprawdź wszystkie konkretne DZIAŁANIA PRAWNE . Jeśli tego mechanizmu nie ma w SOURCE -> is_valid: false.\n\nWAŻNE: Abstrakcyjne pojęcia (np. \"transparentność\", \"zaufanie\") są dozwolone jako wnioski.\n\nOUTPUT (JSON):\n{\n  \"is_valid\": true/false,\n  \"issue\": \"fabricated_entity\" / \"contradiction\" / \"none\"\n}\n\nWYMAGANIA FORMATOWANIA:\n1. Odpowiedz WYŁĄCZNIE surowym obiektem JSON.\n2. NIE używaj bloków kodu Markdown.\n3. NIE dodawaj żadnych wstępów ani wyjaśnień przed ani po JSONie.\n4. JSON musi być poprawny i gotowy do parsowania.\n\n",
      "ai_response_raw": "{\n  \"is_valid\": true,\n  \"issue\": \"none\"\n}"
    },
    {
      "timestamp": "2026-03-31T11:17:57.207Z",
      "source_url": "https://www.congress.gov/119/bills/hr8160/BILLS-119hr8160ih.htm",
      "model": "gemini-flash-latest",
      "prompt_sent": "\nJesteś ekspertem od prawa Stanów Zjednoczonych, który ma za zadanie analizować dokumenty ustaw, uchwał oraz innych dokumentów legislacyjnych, a następnie przygotowywać z nich informacje w przystępny sposób dla obywateli. Twoim celem jest przedstawienie informacji tak, aby obywatele mogli sami ocenić wpływ legislacji na ich życie, nawet bez posiadania specjalistycznej wiedzy legislacyjnej. Skup się na faktach i obiektywnych skutkach wprowadzanych zmian, unikając wartościowania i osobistych opinii. Wszelki żargon prawny jest zabroniony. Prezentuj informacje w jasny, zwięzły i angażujący sposób, tak aby były zrozumiałe dla osoby bez wykształcenia prawniczego. Unikaj długich, złożonych zdań. Zamiast pisać \"projekt ma na celu nowelizację kodeksu podatkowego...\", napisz \"Zmiany w podatkach: nowe ulgi i obowiązki dla...\". Kontynuuj swoją pracę, dopóki nie rozwiążesz swojego zadania. Jeśli nie masz pewności co do generowanej treści, przeanalizuj dokument ponownie – nie zgaduj. Rozplanuj dobrze swoje zadanie przed przystąpieniem do niego. W podsumowaniu i kluczowych punktach, jeśli to możliwe i uzasadnione, podkreśl, jakie konkretne korzyści lub skutki (pozytywne lub negatywne) wprowadza ustawa dla życia codziennego obywateli, ich praw i obowiązków, finansów osobistych, bezpieczeństwa i innych ważnych kwestii (np. kategorycznych zakazów i nakazów czy najważniejszych konkretnych alokacji finansowych i terytorialnych).\n\nTwoja odpowiedź MUSI być w formacie JSON - i zawierać następujące klucze.\nZanim zwrócisz odpowiedź, dokładnie zweryfikuj, czy cała struktura JSON jest w 100% poprawna, włącznie ze wszystkimi przecinkami, nawiasami klamrowymi, kwadratowymi oraz cudzysłowami. Błędny JSON jest nieakceptowalny i uniemożliwi przetworzenie Twojej pracy.\n\nPrzeanalizuj dokładnie poniższy tekst dokumentu prawnego. To jest treść, na podstawie której masz wygenerować podsumowanie i kluczowe punkty:\n--- POCZĄTEK DOKUMENTU ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8160 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8160 To expand research, improve awareness, and increase access to treatment for individuals affected by Premenstrual Dysphoric Disorder, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 30, 2026 Ms. Ansari (for herself, Mrs. Beatty, Mr. Bell, Ms. Brownley, Mr. Carter of Louisiana, Ms. Clarke of New York, Mr. Conaway, Mr. Goldman of New York, Mrs. Grijalva, Mr. Jackson of Illinois, Mr. Johnson of Georgia, Mr. Kennedy of New York, Mr. Krishnamoorthi, Mr. McGarvey, Ms. Norton, Ms. Pressley, Ms. Ross, Mr. Thanedar, Ms. Tlaib, Mr. Tonko, Mrs. Trahan, Ms. Velazquez, Ms. Williams of Georgia, and Ms. Wilson of Florida) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To expand research, improve awareness, and increase access to treatment for individuals affected by Premenstrual Dysphoric Disorder, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Premenstrual Dysphoric Disorder Awareness and Research Act of 2026''. SEC. 2. FINDINGS. Congress finds the following: (1) Premenstrual Dysphoric Disorder (referred to in this section as ``PMDD'') is a severe, chronic, and often disabling medical condition affecting an estimated 5 to 8 percent of women and people assigned female at birth of reproductive age. (2) PMDD is characterized by extreme mood shifts, irritability, depression, anger, hopelessness, tension, anxiety, and physical symptoms, such as difficulty concentrating, change in appetite, decreased energy, over or under sleeping, or joint and muscle aches, in the luteal phase of the menstrual cycle, significantly impairing work, education, and daily life. (3) Despite its prevalence and debilitating impact, PMDD remains under-diagnosed, under-researched, and stigmatized. (4) Early detection, effective treatment, and increased public and provider awareness are essential to improving quality of life for individuals living with PMDD. SEC. 3. RESEARCH WITH RESPECT TO PREMENSTRUAL DYSPHORIC DISORDER (PMDD). (a) In General.--The Secretary of Health and Human Services (in this section referred to as the ``Secretary''), acting through the Director of the National Institutes of Health, shall-- (1) expand and intensify research on Premenstrual Dysphoric Disorder (referred to in this section as ``PMDD''), including the causes, risk factors, diagnosis, and treatment of PMDD; (2) support clinical trials to develop improved treatment options for PMDD; and (3) ensure adequate representation of diverse racial, ethnic, and socioeconomic populations in PMDD-related research. (b) Surveillance and Data Collection.--The Secretary shall collect and publish data on-- (1) the prevalence and incidence of PMDD across populations; (2) the economic and workforce impact of PMDD; and (3) barriers to diagnosis and treatment of PMDD. (c) Authorization of Appropriations.--To carry out this section there are authorized to be appropriated such sums as is necessary for each of fiscal years 2027 through 2031. SEC. 4. EDUCATION AND DISSEMINATION OF INFORMATION WITH RESPECT TO PREMENSTRUAL DYSPHORIC DISORDER (PMDD). (a) In General.--The Secretary shall carry out a public health awareness campaign that is designed to-- (1) raise patient and health care provider awareness of PMDD symptoms and treatment options; (2) reduce stigma associated with menstrual health conditions; and (3) encourage individuals to seek timely medical care. (b) Provider Education.--The Secretary, acting through the Administrator of the Health Resources and Services Administration, shall develop, and disseminate, continuing medical education materials to ensure that health care providers have sufficient knowledge-- (1) to accurately diagnose PMDD; (2) to distinguish PMDD from other mental health and gynecological conditions; and (3) to provide evidence-based care. (c) Coordination.--In carrying out this section, the Secretary shall coordinate with existing awareness, education, and outreach programs and activities of the Department of Health and Human Services. (d) Authorization of Appropriations.--To carry out this section there are authorized to be appropriated such sums as is necessary for each of fiscal years 2026 through 2030. SEC. 5. GRANTS TO TRAIN HEALTH PROFESSIONALS WITH RESPECT TO PMDD. (b) In General.--The Secretary shall award grants to eligible entities for the purpose described in subsection (b). (c) Use of Funds.--A grant awarded under this subsection shall be used to develop, establish, or expand training programs (including accredited residency programs, fellowships, or other related clinical training) for physicians, registered nurses, nurse practitioners, physician assistants, pharmacists, other health care providers, and students and trainees to improve care, treatment, or management services for PMDD. (d) Eligibility.--To be eligible to receive a grant under this subsection, an entity shall-- (1) be-- (A) an accredited school of medicine or osteopathic medicine; (B) an accredited nursing school; (C) an accredited school of pharmacy; (D) an accredited public or nonprofit private hospital; (E) an accredited medical residency program; (F) an accredited nurse practitioner residency program; or (G) a related training program for clinicians, allied health professionals, or social workers that interface with affected populations, which may include hospitals and research institutions, as determined by the Secretary; and (2) submit an application to the Secretary at such time, in such manner, and containing such information as the Secretary may require. (e) Training Opportunities.--In carrying out this section, the Secretary shall expand outreach activities to support and expand training programs, fellowships, and other opportunities for students, faculty, and trainees (including continuing medical education) or establish new training opportunities to address barriers to access to-- (1) primary and specialty care services to support mid-life women's health; and (2) early detection, diagnosis, treatment, and care services for perimenopause, menopausal symptoms, and related chronic conditions. (f) Authorization of Appropriations.--To carry out this section there are authorized to be appropriated such sums as is necessary for each of fiscal years 2027 through 2031. SEC. 6. REPORT ON IMPACTS ON PMDD RESEARCH AND TREATMENT. (a) Report.--Not later than 2 years after the date of the enactment of this Act, the Secretary shall submit to Congress a report on progress made in-- (1) expanding PMDD research; (2) improving awareness of, and education on, PMDD; and (3) increasing access to diagnosis of, and treatment for, PMDD. (b) Authorization of Appropriations.--To carry out this section there are authorized to be appropriated such sums as is necessary for each of fiscal years 2027 through 2031. <all>\n--- KONIEC DOKUMENTU ---\n\nPAMIĘTAJ: Twoja odpowiedź MUSI być wyłącznie poprawnym obiektem JSON. Nie dodawaj żadnych dodatkowych znaków, komentarzy ani tekstu przed znacznikiem '{' ani po znaczniku '}'. Cała odpowiedź musi być parsowalna jako JSON.\nNa podstawie POWYŻSZEGO dokumentu, wypełnij poniższą strukturę JSON:\nOto struktura JSON, której oczekuję (wypełnij ją treścią):\n{\n  \"pl_ai_title\": \"Nowy, krótki tytuł dla aktu prawnego po polsku, oddający sedno wprowadzanych zmian (np. maksymalnie 10-12 słów).\",\n  \"pl_summary\": \"2-3 zdania zwięzłego podsumowania treści aktu prawnego po polsku, napisane z perspektywy wpływu na życie codzienne obywateli.\",\n  \"pl_key_points\": [\n    \"Pierwszy krótki punkt po polsku dotyczący najważniejszych wprowadzanych rozwiązań lub zmian.\",\n    \"Drugi krótki punkt po polsku...\"\n  ],\n  \"eng_ai_title\": \"A new, short title for the legal act in English, capturing the essence of the changes (e.g., max 10-12 words).\",\n  \"eng_summary\": \"2-3 sentences summarizing the legal act in English, from the perspective of its impact on citizens' daily lives.\",\n  \"eng_key_points\": [\n    \"First short bullet point in English regarding the most important solutions or changes being introduced.\",\n    \"Second short bullet point in English...\"\n  ],\n  \"de_ai_title\": \"Ein neuer, kurzer Titel für das Rechtsdokument auf Deutsch, der den Kern der Änderungen erfasst (z.B. max. 10-12 Wörter).\",\n  \"de_summary\": \"2-3 Sätze Zusammenfassung des Rechtsdokuments auf Deutsch, aus der Perspektive seiner Auswirkungen auf das tägliche Leben der Bürger.\",\n  \"de_key_points\": [\n    \"Erster kurzer Stichpunkt auf Deutsch zu den wichtigsten eingeführten Lösungen oder Änderungen.\",\n    \"Zweiter kurzer Stichpunkt auf Deutsch...\"\n  ],\n  \"fr_ai_title\": \"Un nouveau titre court pour l'acte juridique en français, saisissant l'essence des changements (par exemple, 10-12 mots maximum).\",\n  \"fr_summary\": \"Résumé de 2-3 phrases de l'acte juridique en français, du point de vue de son impact sur la vie quotidienne des citoyens.\",\n  \"fr_key_points\": [\n    \"Premier court point en français concernant les solutions ou changements les plus importants introduits.\",\n    \"Deuxième court point en français...\"\n  ],\n  \"es_ai_title\": \"Un nuevo título breve para el acto jurídico en español, que recoja la esencia de los cambios (por ejemplo, máximo 10-12 palabras).\",\n  \"es_summary\": \"Resumen de 2-3 frases del acto jurídico en español, desde la perspectiva de su impacto en la vida cotidiana de los ciudadanos.\",\n  \"es_key_points\": [\n    \"Primer punto breve en español sobre las soluciones o cambios más importantes que se introducen.\",\n    \"Segundo punto breve en español...\"\n  ],\n  \"it_ai_title\": \"Un nuovo titolo breve per l'atto giuridico in italiano, che colga l'essenza delle modifiche (ad es. massimo 10-12 parole).\",\n  \"it_summary\": \"Riepilogo di 2-3 frasi dell'atto giuridico in italiano, dal punto di vista del suo impatto sulla vita quotidiana dei cittadini.\",\n  \"it_key_points\": [\n    \"Primo breve punto in italiano riguardante le soluzioni o le modifiche più importanti introdotte.\",\n    \"Secondo breve punto in italiano...\"\n  ],\n  \"nl_ai_title\": \"Een nieuwe, korte titel voor de rechtshandeling in het Nederlands, die de essentie van de wijzigingen weergeeft (bijv. max. 10-12 woorden).\",\n  \"nl_summary\": \"Samenvatting van 2-3 zinnen van de rechtshandeling in het Nederlands, vanuit het perspectief van de impact op het dagelijks leven van burgers.\",\n  \"nl_key_points\": [\n    \"Eerste korte punt in het Nederlands betreffende de belangrijkste geïntroduceerde oplossingen of wijzigingen.\",\n    \"Tweede korte punt in het Nederlands...\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Primeiro ponto curto em português sobre as soluções ou alterações mais importantes introduzidas.\",\n    \"Segundo ponto curto em português...\"\n  ],\n  \"category\": [\"Categorize the document into one category by default, based on the field it primarily concerns. Choose up to 3 if the document also touches upon SIGNIFICANT issues from other categories. You MUST select categories ONLY from the following list: Health, Education, Family, Taxes, Labor, Security, Environment, Courts and Law, Transport, Benefits, Real Estate, Media and Culture, Local Government, Migration, Agriculture, Public Investments, Informatization, Economy. If the document does not definitively fit any of these, you MUST use \"Other\". If you use \"Other\", it should be the ONLY category selected. Do NOT invent new categories. The response must be an array of strings, e.g., [\"Taxes\", \"Family\"].\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Ustawa o badaniach i świadomości przedmiesiączkowego zaburzenia dysforycznego (PMDD) z 2026 roku\",\n  \"pl_summary\": \"Ustawa ma na celu poprawę opieki nad osobami cierpiącymi na PMDD poprzez zwiększenie funduszy na badania i lepszą edukację lekarzy. Dzięki temu pacjenci mogą liczyć na szybszą diagnozę, skuteczniejsze leczenie oraz mniejszą stygmatyzację problemów zdrowotnych.\",\n  \"pl_key_points\": [\n    \"Zwiększenie funduszy na badania nad przyczynami, czynnikami ryzyka i nowymi metodami leczenia PMDD.\",\n    \"Uruchomienie kampanii informacyjnych dla społeczeństwa i personelu medycznego w celu lepszego rozpoznawania objawów.\",\n    \"Przyznawanie grantów na szkolenia dla lekarzy, pielęgniarek i farmaceutów w zakresie opieki nad pacjentami z PMDD.\",\n    \"Obowiązek zbierania danych na temat wpływu choroby na życie zawodowe, gospodarkę oraz barier w dostępie do leczenia.\"\n  ],\n  \"eng_ai_title\": \"Premenstrual Dysphoric Disorder Awareness and Research Act of 2026\",\n  \"eng_summary\": \"This bill aims to improve the lives of people with PMDD by funding more research and better training for healthcare providers. It focuses on making diagnosis faster and treatments more accessible while reducing the social stigma of the condition.\",\n  \"eng_key_points\": [\n    \"Increased funding for research into PMDD causes, risk factors, and new treatment options.\",\n    \"Public awareness campaigns to help patients and healthcare providers recognize symptoms and seek care.\",\n    \"Grants for training programs to help doctors, nurses, and other health professionals manage PMDD effectively.\",\n    \"Collection of data on how PMDD affects the workforce, the economy, and access to medical services.\"\n  ],\n  \"de_ai_title\": \"Gesetz zur Erforschung und Aufklärung der Prämenstruellen Dysphorischen Störung (PMDD) 2026\",\n  \"de_summary\": \"Dieses Gesetz soll die Versorgung von Menschen mit PMDD verbessern, indem Forschung und medizinische Ausbildung gefördert werden. Ziel ist eine schnellere Diagnose und ein besserer Zugang zu wirksamen Behandlungen im Alltag.\",\n  \"de_key_points\": [\n    \"Mehr Mittel für die Erforschung von Ursachen, Risikofaktoren und neuen Behandlungsmethoden für PMDD.\",\n    \"Aufklärungskampagnen zur Verringerung der Stigmatisierung und zur besseren Erkennung von Symptomen.\",\n    \"Zuschüsse für die Ausbildung von Ärzten, Pflegekräften und Apothekern im Umgang mit PMDD-Patienten.\",\n    \"Datenerhebung über die wirtschaftlichen Auswirkungen der Erkrankung und Hindernisse bei der Diagnose.\"\n  ],\n  \"fr_ai_title\": \"Loi de 2026 sur la recherche et la sensibilisation au trouble dysphorique prémenstruel (TDPM)\",\n  \"fr_summary\": \"Cette loi vise à aider les personnes atteintes de TDPM en finançant la recherche et en formant mieux les professionnels de santé. Elle facilite l'accès au diagnostic et aux soins tout en luttant contre les préjugés.\",\n  \"fr_key_points\": [\n    \"Augmentation des fonds pour la recherche sur les causes, les facteurs de risque et les traitements du TDPM.\",\n    \"Campagnes de sensibilisation pour le public et les médecins afin de mieux reconnaître les symptômes.\",\n    \"Subventions pour former le personnel soignant (médecins, infirmiers, pharmaciens) au diagnostic du TDPM.\",\n    \"Collecte de données sur l'impact de la maladie sur le travail, l'économie et l'accès aux soins.\"\n  ],\n  \"es_ai_title\": \"Ley de Investigación y Concienciación sobre el Trastorno Disfórico Premenstrual (TDPM) de 2026\",\n  \"es_summary\": \"Esta ley busca mejorar la vida de quienes padecen TDPM mediante más investigación y mejor capacitación para los médicos. El objetivo es lograr diagnósticos más rápidos y tratamientos efectivos para los ciudadanos afectados.\",\n  \"es_key_points\": [\n    \"Más fondos para investigar las causas, factores de riesgo y nuevas opciones de tratamiento del TDPM.\",\n    \"Campañas de salud pública para reducir el estigma y ayudar a reconocer los síntomas a tiempo.\",\n    \"Becas para capacitar a médicos, enfermeros y farmacéuticos en el manejo adecuado de esta condición.\",\n    \"Seguimiento del impacto económico y laboral del TDPM, así como de las barreras para recibir tratamiento.\"\n  ],\n  \"it_ai_title\": \"Legge del 2026 sulla ricerca e la sensibilizzazione sul disturbo disforico premestruale (PMDD)\",\n  \"it_summary\": \"Questa legge mira a sostenere le persone affette da PMDD aumentando i fondi per la ricerca e migliorando la formazione medica. L'obiettivo è garantire diagnosi più accurate e un accesso facilitato alle cure necessarie.\",\n  \"it_key_points\": [\n    \"Incremento dei fondi per studiare cause, fattori di rischio e nuove cure per il PMDD.\",\n    \"Campagne di sensibilizzazione per ridurre lo stigma sociale e incoraggiare la ricerca di assistenza medica.\",\n    \"Finanziamenti per la formazione di medici, infermieri e farmacisti sulla diagnosi e gestione del PMDD.\",\n    \"Raccolta dati sull'impatto della malattia sulla vita lavorativa e sulle barriere all'accesso alle cure.\"\n  ],\n  \"nl_ai_title\": \"Wet op onderzoek en bewustwording van de Premenstruele Dysfore Stoornis (PMDD) van 2026\",\n  \"nl_summary\": \"Deze wet is bedoeld om de zorg voor mensen met PMDD te verbeteren door meer onderzoek en betere scholing voor artsen. Dit moet leiden tot snellere diagnoses en betere ondersteuning in het dagelijks leven.\",\n  \"nl_key_points\": [\n    \"Extra geld voor onderzoek naar de oorzaken, risicofactoren en behandeling van PMDD.\",\n    \"Voorlichtingscampagnes voor het publiek en zorgverleners om symptomen beter te herkennen.\",\n    \"Subsidies voor de opleiding van artsen, verpleegkundigen en apothekers over PMDD-zorg.\",\n    \"Onderzoek naar de impact van de aandoening op werk, de economie en de toegang tot zorg.\"\n  ],\n  \"pt_ai_title\": \"Lei de Pesquisa e Conscientização sobre o Transtorno Disfórico Pré-Menstrual (TDPM) de 2026\",\n  \"pt_summary\": \"Esta lei visa melhorar a vida das pessoas com TDPM através do aumento do financiamento para pesquisa e formação de profissionais de saúde. O foco é garantir diagnósticos mais rápidos e tratamentos eficazes para a população.\",\n  \"pt_key_points\": [\n    \"Mais recursos para pesquisar as causas, fatores de risco e novos tratamentos para o TDPM.\",\n    \"Campanhas de conscientização pública para reduzir o preconceito e incentivar a busca por ajuda médica.\",\n    \"Subsídios para treinar médicos, enfermeiros e farmacêuticos no diagnóstico e manejo do TDPM.\",\n    \"Coleta de dados sobre o impacto da doença no trabalho, na economia e no acesso aos serviços de saúde.\"\n  ],\n  \"category\": [\"Health\"]\n}"
    }
  ]
}